Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives $22.40 Average PT from Analysts

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have earned an average recommendation of “Hold” from the eleven brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $21.80.

Several research firms have recently issued reports on SBRA. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Saturday. Wells Fargo & Company increased their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. UBS Group set a $19.00 target price on shares of Sabra Healthcare REIT in a research note on Thursday. Raymond James Financial began coverage on shares of Sabra Healthcare REIT in a research note on Wednesday. They set an “underperform” rating on the stock. Finally, Cantor Fitzgerald increased their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th.

Institutional Trading of Sabra Healthcare REIT

Several institutional investors have recently added to or reduced their stakes in SBRA. Principal Financial Group Inc. boosted its position in Sabra Healthcare REIT by 21.6% in the 4th quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after buying an additional 4,431,897 shares during the period. Lasalle Investment Management Securities LLC purchased a new position in Sabra Healthcare REIT in the 4th quarter valued at approximately $66,938,000. Norges Bank purchased a new position in Sabra Healthcare REIT in the 4th quarter valued at approximately $57,945,000. Sumitomo Mitsui Trust Group Inc. boosted its position in Sabra Healthcare REIT by 1,019.8% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after buying an additional 2,736,993 shares during the period. Finally, Balyasny Asset Management L.P. purchased a new position in Sabra Healthcare REIT in the 2nd quarter valued at approximately $49,955,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Price Performance

NASDAQ:SBRA opened at $18.12 on Wednesday. Sabra Healthcare REIT has a one year low of $17.17 and a one year high of $21.28. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The firm has a market cap of $4.57 billion, a price-to-earnings ratio of 28.76, a PEG ratio of 1.35 and a beta of 0.64. The firm’s fifty day moving average is $19.90 and its two-hundred day moving average is $19.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. During the same period in the prior year, the company earned $0.37 earnings per share. The firm’s revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts expect that Sabra Healthcare REIT will post 1.5 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.6%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is presently 190.48%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.